Immunotherapy known as VDTP/GcMaf is a naturally occurring protein. Here we reveal yet further evidence of its effectiveness and especially in the role it plays with the overall health of our vital organs.
We often see it also described as Vitamin D Binding Transport Protein. Its role is to essentially take the Vitamin/Hormone D3 that we receive from the sun, or supplements and transport it through the immune system, repairing and rebuilding damaged whilst attacking pathogens.
We all have GcMAF in our bodies, as it is a naturally occurring protein. The likelihood is that if you are well and healthy, you have enough of it to fight off cancer and pathogens. If on the other hand you are sick or have been diagnosed with a serious condition, then your immune system is low and so your GcMAF/VDTP is too. If you have cancer or autism, for example, then you are so low in it, that you need of a boost. An injection of external GcMAF/VDTP, alongside some lifestyle changes and a cleaner diet.
The evidence, research and real cancer and autism stories that prove the effectiveness of GcMAF/VDTP Immunotherapy, even against the rarest of cancers, is abundant. One of the issues is that it is not a well-publicised story. If you asked most people in the street what their idea of a cure for cancer would be, they would say chemotherapy. They may also mention some radiation or surgery.
But the fact is that chemotherapy is just as deadly as cancer, even though it is never recorded as the cause of death. In fact, it is arguably more deadly with the statistics now showing that it kills at least 50% of cancer sufferers. Begging the question – why damage the immune system further when it is at this stage in the cycle of health that GcMAF is most needed.
If you are having problems sourcing a genuine product, please contact: [email protected] for more enquiries on VDPT/GcMaf
It has never harmed anyone and certainly has never killed a single person. As we are dealing with something natural, which as we all know means that it cannot be patented and cannot be owned by Big Pharma. At least not properly.
So the market has been flooded with fake VDTP/GcMAF products that do not work. You cannot make this in your kitchen at home and it is not made from Colostrum, for example.
GcMAF and the role it plays in our organs
Please see this following independently published research, that breaks down the proof that the original vitamin D binding protein known as GcMAF is distributed within the body, whilst also determining how each organ expresses the protein in the needed ratio, for that organ to best function.
This information looks in-depth at the different issues within cells and tissue and organ pathology including the cell lining.
It is yet further proof that GcMAF is a vital component for our bodies, as you will see clearly marked in the figure of each individual organ, especially the liver, kidney and gallbladder.
This is also proof that as MD Simon Fermun stated in his informative article about the advancement of Immunotherapy GcMAF and how we can merge the medical worlds, GcMAF can be a great aid to chemotherapy, as it could potentially help prevent much of the damage that these lethal drugs induce.
Repair the DNA
Even more excitingly GcMAF is extremely useful at the beginning of most treatment plans, as this research proves, for it allows the organs of the body to repair and to return to their full function. Thus giving the body the very best chance at attacking any tumours or damage.
For the very best results, we then commence targeting the exact genes that are in need of repair, according to each cell type, so there is no heavy intake or burden on any other cells and we can target and repair the exact cells that are damaged and are causing the body to be sick in the first place.
We work on this until the DNA is fixed, working with a specialist in DNA and have been doing so over the past for 3 months. This is cutting edge gene therapy combined with immunotherapy that creates incredible results.
These are somewhat early days as we say, but the results have been amazing, it so wonderful to work together and we hope we can help more people in the future this way. The sad truth though is that it is very time-consuming and our time is limited and so alas we are to only able to help a low number of patients.
Of course, this is tough. But many many people can benefit from the use of GcMAF, alongside lifestyle and dietary changes.
Please note that both GcMaf from Bulgaria and Japan are the only sources of GcMaf. Both products are equally as good on quality of strength, assays and product. we have also just been informed that sadly Isreal no longer produces GcMaf. Shipping is faster with Bulgaria and easy payment options. GcMaf is the biggest advancement in the treatment of autism and cancer and immune disorders having had undeniable results.
In fact, it shows promising positive effects when coupled with Autism spectrum therapies. GcMAF is a promising contender for autism spectrum disorder treatment.
If you are having problems sourcing a product, here is one link where you can source VDPT/GcMaf
You might be wondering what is Autism spectrum disorder? Well, Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication and restricted/repetitive behaviours. The effects of ASD and the severity of symptoms are different in each person. This condition is alleviated through Autism spectrum therapies – and GcMAF is an effective alternative if administered by an experienced medical practitioner.
How does GcMAF actually work?
GcMAF immunotherapy has been described as the PacMan of the immune system. Please watch the video below (made under a time-lapse microscope) that shows immune cells attacking and eliminating viruses, bacteria and cancer. It shows in fast forward just how GCMAF works on a cellular level, as it constantly seeks out pathogens and destroys them, even repairing nerve cell damage.
It would seem the next move would be to manufacture it through mainstream medicine, and we can only hope that one day this will happen. Imagine a time when it is readily available to everyone for free, from the NHS in the UK to the Insurance listings and Hospitals all over the world? Cancer will decrease and many lives will be saved.
Other studies show patients that were suffering from advanced cancers, within a few weeks, their tumour volume had decreased by an average of 25%.
While some clinical results were compared to chemo in tumour-shrinking power, OA- complexed GcMAF, along with some other types of OA- complexed proteins, destroys cancer cells without any ill effects on healthy cells.
One patient discussed in research is a 56-year-old man suffering from a recurrence of metastatic squamous cell carcinoma that was “successfully” treated with chemo and radiation. Because of his cancer’s location, GcMAF was administered by both nebulizer and subcutaneous injections. Even after only 5 days of treatment, ultrasonography had shown that his tumours had shrunk by approximately one quarter. He also reported improvement in breathing, with ventilation in the apical right lobe improving.
Another patient was a 62-year-old woman with “extensive” breast cancer and no history of conventional treatment. Within one week, the diameter of the two main lymph metastases (the primary tumour was unable to be measured due to size) shrunk from 3.9 to 3.46cm.
Other documented cases show similar results. For example, a 63-year-old woman with colon cancer that later spread to her lungs and liver experienced a reduction in her liver tumour from 13 to 6.6mL in only 2 weeks of treatment! This was once again achieved by alternating nebulization and injection of OA-GcMAF.
Another patient was a 43-year old woman with metastatic breast cancer to the bone and liver. After 1 week of both inhaled OA-GcMAF and that injected into her breast, her primary tumour shrunk from 1.8 to 1.3 mL, which was considered representative of four other cases.
Some are less dramatic, such as that of a man in his 30’s who experienced a reduction in one of his melanoma metastases from 52.1 to 48.6mm.
Does GcMaf work for HIV?
GcMaf has been very successful with HIV.
To sabotage the immune system and put macrophages to sleep, all viruses make Nagalase, the enzyme that blocks the production of GcMAF. Without GcMAF (the protein that activates macrophages and jump-starts the entire immune response) HIV and other viruses can grow unimpeded. Nagalase puts the immune system to sleep. Dr Nobuto Yamamoto demonstrated that GcMAF administration bypasses the Nagalase blockage and re-activates the macrophages, which then proceed to kill the HIV viruses and cure the infection.
Something to cheer about?
People infected with the Human Immunodeficiency Virus (HIV) have something to get excited about when it comes to GcMAF.
In 2009 Dr Nobuto Yamamoto published a landmark paper entitled: “Immunotherapy of HIV-Infected Patients With Gc Protein-Derived Macrophage Activating Factor (GcMAF)” in the Journal of Medical Virology in which he demonstrated that GcMAF cured 100% of nonanemic HIV infected patients. After seven years of follow-up, there were no recurrences. All patients maintained healthy CD+ counts. I am experiencing the very same with our patients at the clinic.
Of course, this is just one study. And it had the disadvantage of containing some complex molecular biological chemo-speak. If the reader weren’t familiar with Yamamoto’s decades of background research (all of which was published in journals that HIV researchers and patients wouldn’t be likely to read), this study would fall on deaf ears. But Professor Yamamoto’s HIV study was no quirk. Based on a quarter-century of solid research that predicted success long before the actual human trials, it presented all the science one would need to understand exactly why these HIV patients were cured.
Though this study was published in 2009, there has been no informed discussion on this topic, no further GcMAF research as a therapy for HIV, and no media chatter. It’s as if this study never happened. Why is this?
How GcMAF destroys HIV
HIV—like all viruses—makes Nagalase, the enzyme that blocks GcMAF production. Without GcMAF, macrophages become indolent and the anti-viral immune response shuts down. This allows HIV infection to spread. To remedy this situation, Dr Yamamoto simply gave these patients GcMAF. This reactivated the sleeping macrophages, which then proceeded to phagocytize all of the viruses.
The precise molecular biological pathways and mechanisms involved with HIV, Nagalase, and GcMAF are identical to those for cancer cells, and need not be repeated here.
In his HIV study, Yamamoto first showed that HIV patients had high Nagalase levels which correlated with their high HIV RNA levels (a way to measure the amount of HIV infection). Then, as he administered GcMAF (100 ng. once a week for 18 weeks), all patients’ Nagalase levels gradually went down to control levels, and, in tandem with the Nagalase, viral load went down to zero. Yamamoto wrote that these data “suggest that these patients were free of both HIV virions and HIV-infected cells.”
Professor Yamamoto followed these patients for seven years, and their viral load (HIV-1 RNA), CD4 counts (helper cells, a type of lymphocyte used to evaluate immunocompetence), p24 antigen (HIV-specific antigen), viral culture, and Nagalase levels remained normal. All patients continued to be free of disease. (Note: anaemic HIV patients were excluded from this study. Anaemia is common in HIV patients. The effect of GcMAF on anaemic HIV patients is thus unknown.)
I personally have followed our patients for 3 years after taking the GcMAF protocols, we confirm that all 6 patients remain HIV free, we continue to follow the results until 10 years have been reached. GcMAF continues to prove the most effective protocol for HIV.
Please see this video for a full explanation of how GcMAF works
And watch this video captured in time lapse showing how activated GcMAF cells attack and eliminate viruses, bacteria and cancer:
How your body makes GcMAF
GcMAF and Nagalase are both proteins, so let me start with a brief—and hopefully painless—a primer on proteins. Do you know those birthday present bows made of clusters of curly ribbons? Under a very powerful microscope, proteins look like that. The ribbons are long chains of hundreds of amino acids that make up a protein molecule. Our DNA is programmed to make tens of thousands of different proteins, and what makes them different is the ordering of the amino acids. Each strand (usually there are three or four of them) of curled ribbon in our birthday bow is one of those chains. The curly ribbons are all attached together where the bow is fastened to the present. They may look like a big blob of randomly-placed bands—and in the ribbon, they are. But in a protein, there is a very specific three-dimensional structure, such that even though the curly ribbons look randomly placed, they are, in fact, very precisely positioned—and even slight positional changes will significantly alter the nature of the protein.
Vitamin D Transport protein (VDTP) is the precursor protein out of which our immune cells make GcMAF. Up close DBP looks kind of like a small Brillo pad, but the convolutions are not sharp-edged; they’re actually quite soft and sticky. DBP contains 458 amino acids, one of which is very special and quite different from all the others. This is a threonine amino acid, the 420th amino acid in its chain. Attached to this threonine is a group of three sugars. The presence of these sugars defines the purpose of the entire DBP protein molecule. To keep things simple, I am going to name the three sugar molecules after candy bars.
Because Vitamin D Binding Protein comes with sugars attached, we can now refer to it as a glycoprotein. Most of the immune system’s “messenger molecules” are glycoproteins.
Now imagine DBP as this large protein with three sugars (or candy bars) attached. The first is a Hershey’s bar, the second is a Milky Way, and the third is a Snickers. All three are attached to one another, as shown in the diagram, in an upside-down “Y”-shaped configuration.
Vitamin D-binding Protein (VDTP) is the starting point in GcMAF production.
DBP is the protein from which we are going to make GcMAF.
The dashes (–) indicate chemical bonds (pairs of electrons that hold atoms together to form chemicals) that attach the sugars to each other and to the protein.
Making GcMAF from VDTP
Now let’s transform our candy bar model of VDTP into GcMAF. There are two steps in this process. The first step is to snip off the Milky Way bar. (This is performed by the enzyme beta-galactosidase which is embedded in the outer cell membrane of B-lymphocytes.) You can go ahead and eat it; we won’t need it anymore. If you don’t want it, your body will just recycle it. Intermediate in GcMAF production.
The second step is to snip off the Snickers bar. (This is performed by the enzyme sialidase, which is located in the outer membrane of T-lymphocyte cells.) (You can have that one too if you want to get on the fast track to diabetes.)
Now we’re left with a huge protein that has just the remaining Hershey’s hanging off of it. Guess what: this is GcMAF.
By snipping off two of the three sugars (first the Milky Way and then the Snickers bar), we have transformed the Vitamin D-binding Protein into GcMAF.
It’s fully formed and ready to float off, find a macrophage, lock onto its receptor, and then send a powerful message to the entire cell, telling it to get to work tackling microbes and killing cancer cells. And, as you know, when GcMAF talks, macros listen.
Just for the record (and for you biochemists in the house) my Hershey’s bar is alpha-N-acetylgalactosamine (GalNAc), the Milky Way is D-galactose, and the Snickers bar is sialic acid (also known as N-acetylneuraminic acid).
Please email [email protected] for further information
Love and Light
The Healing Oracle Team
Please join our growing numbers on MeWe: Healing Oracle
Also join us on Twitter | YouTube
Please sign our global petition against enforced vaccinations The intention of this petition is to present 5 million signatures to each President, Prime Minister, Health Minister and heads of state worldwide.
Vaccines are a global problem and need to be tackled on a global level.
If we stand as one, we have a chance of saving the children of the future.
Keep Us Advertising Free
Healing Oracle is made possible by the support of its readers. If you find the posts and resources useful, please consider making a contribution to support us (in any amount) so we can continue to inform and assist people around the world. We feel that giving a voice to those who have transformed their health, or that of a loved one, with alternative treatment is an important mission. Thank you for valuing our work and helping it to continue.
Donate. Should you choose to kindly donate towards our time and efforts, please use the ‘donations’ box above on the top right hand side (on Desktop), or the donations box below (on Mobile)